Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Boston Scientific
(NY:
BSX
)
62.00
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Boston Scientific
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
The Great Rebound: US Megadeals Surge 319% as Corporate Consolidation Returns with a Vengeance
April 01, 2026
The first quarter of 2026 has signaled a definitive end to the "deal drought" that plagued the previous three years, as American corporations embark on an unprecedented wave of consolidation. Driven by...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
The Medtronic Transformation: A Deep Dive into the Future of a MedTech Titan
April 01, 2026
As of April 1, 2026, the global medical technology landscape is undergoing a profound shift, and at the center of this evolution is Medtronic plc (NYSE: MDT). Long regarded as the "sleeping giant" of...
Via
Finterra
Topics
Artificial Intelligence
Economy
Initial Public Offering
Boston Scientific Corp (NYSE:BSX) Presents a Compelling Mix of Strong Fundamentals and Technical Breakout Potential
↗
March 28, 2026
Via
Chartmill
Boston Scientific Corp (NYSE:BSX): A GARP Stock with Strong Growth and Reasonable Valuation
↗
March 12, 2026
Via
Chartmill
The New Blue-Chip: How Johnson & Johnson Refined Its Empire for a High-Growth Future
April 01, 2026
As we enter the second quarter of 2026, Johnson & Johnson (NYSE: JNJ) stands as a starkly different entity than the consumer-facing conglomerate that defined the 20th century. Having successfully shed...
Via
Finterra
Topics
Artificial Intelligence
Earnings
Economy
Deep Dive: Boston Scientific (BSX) and the New Era of Medical Device Dominance
March 31, 2026
Date: March 31, 2026 Introduction Boston Scientific Corporation (NYSE: BSX) finds itself at a critical crossroads this morning. After a year of record-breaking growth and the successful launch of its...
Via
Finterra
Topics
Lawsuit
Product Recall
Stocks making big moves yesterday: Avis Budget Group, Boston Scientific, CLEAR Secure, DNOW, and Comcast
March 31, 2026
Check out the companies making headlines yesterday: Avis Budget Group (NASDAQ:CAR): Car rental services provider Avis (NASDAQ:CAR) fell by 9% on Monday after...
Via
StockStory
Topics
Government
Stock Market Today, March 30: Boston Scientific Falls After Delivering Underwhelming Trial Results
↗
March 30, 2026
Today, March 30, 2026, investors send Boston Scientific shares lower as they dig deeper into the company's latest trial update.
Via
The Motley Fool
Topics
Stocks
Boston Scientific (BSX) Stock Trades Down, Here Is Why
March 30, 2026
What Happened? Shares of medical device company Boston Scientific (NYSE:BSX) fell 9.4% in the afternoon session after Raymond James downgraded the stock to O...
Via
StockStory
Uncover the latest developments among S&P500 stocks in today's session.
↗
March 30, 2026
Via
Chartmill
Which S&P500 stocks are the most active on Monday?
↗
March 30, 2026
Via
Chartmill
Exploring the top movers within the S&P500 index during today's session.
↗
March 30, 2026
Via
Chartmill
These S&P500 stocks are gapping in today's session
↗
March 30, 2026
Via
Chartmill
These S&P500 stocks that are showing activity before the opening bell on Monday.
↗
March 30, 2026
Via
Chartmill
The $1 Trillion Resurrection: Global M&A Hits Historic Milestone in Q1 2026 as Jefferies Eyes 'Strategic Renaissance'
March 27, 2026
The global mergers and acquisitions (M&A) market has roared back to life in the first quarter of 2026, shattering expectations and signaling a definitive end to the dealmaking drought of previous...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Initial Public Offering
Why Boston Scientific's Big Dip Could Be a Bigger Opportunity
↗
March 24, 2026
Via
MarketBeat
The Record-Breaking M&A Renaissance of 2026: Why Deal Values are Soaring as Volume Dips
March 19, 2026
As the first quarter of 2026 draws to a close, the U.S. financial landscape has been reshaped by a staggering surge in corporate consolidation. Total deal value for the quarter reached a historic...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Workforce
The High-Stakes Gambit: How Healthcare Giants are 'Front-Loading' Megadeals to Outrun Regulatory Storms
March 18, 2026
In the face of the most aggressive antitrust environment in decades and the sweeping legislative changes of the 2025 "One Big Beautiful Bill Act" (OBBBA), the healthcare sector has not retreated from...
Via
MarketMinute
Topics
Artificial Intelligence
Intellectual Property
Movers and shakers in today's after-hours session for S&P500 stocks?
↗
March 16, 2026
Via
Chartmill
Which stocks are moving after the closing bell on Monday?
↗
March 16, 2026
Via
Chartmill
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment
↗
March 15, 2026
EyePoint develops sustained-release treatments for retinal diseases, leveraging proprietary technology and strategic industry partnerships.
Via
The Motley Fool
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement
↗
March 15, 2026
This medical technology firm delivers advanced noninvasive monitoring and automation solutions to healthcare providers worldwide.
Via
The Motley Fool
Topics
Regulatory Compliance
This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares
↗
March 15, 2026
This biotech firm develops therapies targeting cystic fibrosis, with shares up nearly 90% year-over-year as of the latest filing.
Via
The Motley Fool
This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share
↗
March 15, 2026
RAPT Therapeutics develops oral therapies for cancer and inflammation, with key drug candidates currently in clinical trials.
Via
The Motley Fool
This $9 Million Institutional Buy Targeted a Semiconductor Stock Down 19% Over the Past Year
↗
March 11, 2026
Skyworks Solutions delivers semiconductor products for wireless and analog applications across diverse global markets.
Via
The Motley Fool
Topics
Regulatory Compliance
OLED Stock Down 35% This Past Year, but One Fund Invested $9 Million More Anyway
↗
March 11, 2026
Universal Display licenses OLED tech and supplies materials to major players in the global display and lighting markets.
Via
The Motley Fool
Topics
Intellectual Property
Regulatory Compliance
1 Profitable Stock to Research Further and 2 Facing Challenges
March 11, 2026
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via
StockStory
The $2.5 Trillion Tsunami: Why 2026 has Become the Year of the Megadeal
March 10, 2026
As of March 10, 2026, the United States financial markets are witnessing an unprecedented explosion in Mergers and Acquisitions (M&A) that has caught even the most optimistic analysts by surprise....
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Government
The 2026 M&A Resurgence: Private Equity Confidence Hits Record Highs
March 09, 2026
The U.S. Mergers and Acquisitions (M&A) landscape has entered a blistering new phase of activity, shaking off the volatility of the mid-2020s to reach levels of engagement not seen in over half a...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Government
3 Reasons Boston Scientific Stock Could Quietly 5X as the World Ages
↗
March 05, 2026
The beaten-down company is worth considering amid a major demographic shift underway now.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.